Literature DB >> 17397780

Minimizing complications of endoscopic ultrasound and EUS-guided fine needle aspiration.

Janak N Shah1, V Raman Muthusamy.   

Abstract

Endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration have become important tools in evaluation of patients who have various gastrointestinal and nongastrointestinal disorders, and are being increasingly utilized at many centers. With over 10 years of worldwide published clinical data, the collective experience suggests that EUS is a safe tool. There are various measures that may be undertaken to help minimize the risks. In light of ongoing advances in interventional techniques and recognition of new procedural indications, the safety of all types of procedures and efforts to minimize EUS-related complications need to be periodically reexamined.

Entities:  

Mesh:

Year:  2007        PMID: 17397780     DOI: 10.1016/j.giec.2006.10.002

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  3 in total

1.  The role of endoscopic ultrasound and cyst fluid analysis in the initial evaluation and follow-up of incidental pancreatic cystic lesions.

Authors:  Andrei Cocieru; Steven Brandwein; Pierre F Saldinger
Journal:  HPB (Oxford)       Date:  2011-06-07       Impact factor: 3.647

2.  Feasibility and yield of screening in relatives from familial pancreatic cancer families.

Authors:  Emmy Ludwig; Sara H Olson; Sharon Bayuga; Jennifer Simon; Mark A Schattner; Hans Gerdes; Peter J Allen; William R Jarnagin; Robert C Kurtz
Journal:  Am J Gastroenterol       Date:  2011-04-05       Impact factor: 10.864

3.  Risk factors associated with adverse events during endoscopic ultrasound-guided tissue sampling.

Authors:  Kwang Hyuck Lee; Eun Young Kim; Juhee Cho; Danbee Kang; Seungmin Bang; Hyung Kil Kim; Gwang Ha Kim; Hyun Jong Choi; Joung-Ho Han; Seong Woo Jeon; Ji Kon Ryu; Jeong Seop Moon; Tae Hee Lee; Jin Woong Cho; Tae Hyeon Kim; Young Koog Cheon; Chang-Hwan Park; Jong Kyun Lee; Jong Ho Moon; Chang Min Cho
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.